Retatrutide 30MG
$550.00
Sale price
$550.00
Regular price
Skip to product information
Retatrutide 30MG offers a larger supply of the triple GLP-1/GIP/glucagon receptor agonist for extended research protocols. This high-dose formulation is ideal for long-term studies examining the metabolic, cardiovascular, and body composition effects of triple incretin receptor co-agonism.
Key Benefits:
• Extended research supply
• Triple incretin receptor agonism
• Substantial fat mass reduction
• Improved glycemic control
• Cardiovascular benefit research
Retatrutide 30MG
$550.00
Sale price
$550.00
Regular price
Key Benefits:
• Extended research supply
• Triple incretin receptor agonism
• Substantial fat mass reduction
• Improved glycemic control
• Cardiovascular benefit research